Download
Forns-et-al_2019_Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014_Incidence and comorbidities of antidepressant initiators.pdf 1,19MB
WeightNameValue
1000 Titel
  • Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiators
1000 Autor/in
  1. Forns, Joan |
  2. Pottegård, Anton |
  3. Reinders, Tammo |
  4. Poblador-Plou, Beatriz |
  5. Morros, Rosa |
  6. Brandt, Lena |
  7. Cainzos-Achirica, Miguel |
  8. Hellfritzsch, Maja |
  9. Schink, Tania |
  10. Prados-Torres, Alexandra |
  11. Giner-Soriano, Maria |
  12. Hägg, David |
  13. Hallas, Jesper |
  14. Cortés, Jordi |
  15. Jacquot, Emanuelle |
  16. Deltour, Nicolas |
  17. Perez-Gutthan, Susana |
  18. Pladevall, Manel |
  19. Reutfors, Johan |
1000 Erscheinungsjahr 2019
1000 LeibnizOpen
1000 Art der Datei
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2019-02-06
1000 Erschienen in
1000 Quellenangabe
  • 249: 242-252
1000 FRL-Sammlung
1000 Copyrightjahr
  • 2019
1000 Lizenz
1000 Verlagsversion
  • http://dx.doi.org/10.1016/j.jad.2019.02.010 |
1000 Ergänzendes Material
  • https://www.sciencedirect.com/science/article/pii/S016503271832398X?via%3Dihub#sec0022 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • BACKGROUND: We aimed to describe patterns of use and characteristics of 10 commonly used antidepressants for the period 2009–2014 in Denmark, Germany, Spain, and Sweden. METHODS: Adult initiators from 2009 to 2014 of each study antidepressant were identified in four countries using five data sources: the Danish National registers, GePaRD (Germany), EpiChron (Aragon, Spain), SIDIAP (Catalonia, Spain), and the Swedish National Registers. The study included 10 study antidepressants: citalopram, escitalopram, fluoxetine, paroxetine, sertraline, duloxetine, venlafaxine, amitriptyline, mirtazapine, and agomelatine.RESULTS: Citalopram was the most prescribed study antidepressant, followed by mirtazapine. Paroxetine and agomelatine were the least prescribed antidepressants. Mirtazapine was widely used among older antidepressant initiators with higher percentages of comorbidities at baseline, and fluoxetine was used among young patients. Citalopram and amitriptyline had the lowest percentage of multiple antidepressant use in the 12 months prior to the current treatment episode, while agomelatine, duloxetine, and venlafaxine had the highest percentage of multiple antidepressant use in the year prior to the current treatment episode. LIMITATIONS: The most important limitations are exposure information based on filled prescriptions, focus on antidepressant initiators only, lack of information on the indication, and heterogeneity of the type of data across data sources. CONCLUSIONS: Results of this study including 4.8 million study antidepressant initiators of study antidepressants suggest that citalopram and mirtazapine are the most commonly prescribed antidepressants. Agomelatine and paroxetine were the least used antidepressants in the participating populations. Mirtazapine was the antidepressant most commonly prescribed among older antidepressant initiators with high percentage of comorbidities at baseline, whereas fluoxetine was commonly used among young patients.
1000 Sacherschließung
lokal Drug utilization study
lokal Antidepressants
lokal Comorbidity
lokal Europe
1000 Fachgruppe
  1. Medizin |
  2. Gesundheitswesen |
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/creator/Rm9ybnMsIEpvYW4=|https://frl.publisso.de/adhoc/creator/UG90dGVnw6VyZCwgQW50b24=|https://frl.publisso.de/adhoc/creator/UmVpbmRlcnMsIFRhbW1v|https://frl.publisso.de/adhoc/creator/UG9ibGFkb3ItUGxvdSwgQmVhdHJpeg==|https://frl.publisso.de/adhoc/creator/TW9ycm9zLCBSb3Nh|https://frl.publisso.de/adhoc/creator/QnJhbmR0LCBMZW5h|https://frl.publisso.de/adhoc/creator/Q2Fpbnpvcy1BY2hpcmljYSwgTWlndWVs|https://frl.publisso.de/adhoc/creator/SGVsbGZyaXR6c2NoLCBNYWph|https://orcid.org/0000-0002-0224-1866|https://frl.publisso.de/adhoc/creator/UHJhZG9zLVRvcnJlcywgQWxleGFuZHJh|https://frl.publisso.de/adhoc/creator/R2luZXItU29yaWFubywgTWFyaWE=|https://frl.publisso.de/adhoc/creator/SMOkZ2csIERhdmlk|https://frl.publisso.de/adhoc/creator/SGFsbGFzLCBKZXNwZXI=|https://frl.publisso.de/adhoc/creator/Q29ydMOpcywgSm9yZGk=|https://frl.publisso.de/adhoc/creator/SmFjcXVvdCwgRW1hbnVlbGxl|https://frl.publisso.de/adhoc/creator/RGVsdG91ciwgTmljb2xhcw==|https://frl.publisso.de/adhoc/creator/UGVyZXotR3V0dGhhbiwgU3VzYW5h|https://frl.publisso.de/adhoc/creator/UGxhZGV2YWxsLCBNYW5lbA==|https://frl.publisso.de/adhoc/creator/UmV1dGZvcnMsIEpvaGFu
1000 Förderer
  1. Les Laboratoires Servier |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
  1. Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiators
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Les Laboratoires Servier |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6413212.rdf
1000 Erstellt am 2019-03-04T15:13:35.375+0100
1000 Erstellt von 266
1000 beschreibt frl:6413212
1000 Bearbeitet von 122
1000 Zuletzt bearbeitet Wed Mar 06 14:31:14 CET 2019
1000 Objekt bearb. Wed Mar 06 13:15:53 CET 2019
1000 Vgl. frl:6413212
1000 Oai Id
  1. oai:frl.publisso.de:frl:6413212 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source